Frank T. Watkins, Director at Shockwave Medical, Inc. (SWAV), sold 2,000 shares at $232.29 ($464K) on 2024-02-06, disclosed to the SEC on 2024-02-07.
Scheduled sale ($464k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $231.11 | 900 | $208K | 44.9% |
| 2 | $232.29 | 1,100 | $256K | 55.1% |
| Total | $231.76 avg | 2,000 | $464K | 100% |
| Filing → |
| SWAV | SELL | 2023-11-21 | $926K | — | Filing → |
| SWAV | SELL | 2023-10-23 | $608K | — | Filing → |
| SWAV | SELL | 2023-09-21 | $628K | — | Filing → |